๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of chromotherapy on lymphocytes and on human tumor xenografts in nude mice

โœ Scribed by I. K. Bukharova; L. I. Osokina; T. I. Milovanova

Publisher
Springer US
Year
1987
Tongue
English
Weight
273 KB
Volume
103
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Effects of hyperthermia and iodine-131 l
Effects of hyperthermia and iodine-131 labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice
โœ Bharat B. Mittal; A. Michael Zimmer; Vythialingam Sathiaseelan; Steven T. Rosen; ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 698 KB

Background. Many studies have demonstrated synergistic interaction between hyperthermia and radiation. This study was undertaken to determine whether hyperthermia could enhance the effect of radioimmunotherapy (RIT) in the treatment of human colon adenocarcinoma xenografts in nude mice. The experim

Antitumor efficacy of taxane liposomes o
Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice
โœ Amarnath Sharma; Ralph J. Bernacki; Robert M. Straubinger; Iwao Ojima ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 724 KB

Taxanes such as paclitaxel (Taxol) and docetaxel (Taxotere) are promising agents for use against ovarian cancer and other malignancies. Recently, SB-T-1011, a semisynthetic taxane, has been prepared from 14-hydroxy-10-deacetylbaccatin III. SB-T-1011 shows similar or greater in vitro cytostatic activ

Experimental studies on biochemical modu
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice
โœ Ryungsa Kim; Naoki Hirabayashi; Masahiko Nishiyama; Kazuto Jinushi; Tetsuya Toge ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 755 KB

Topoisomerase (topo) I and II are nuclear enzymes which are novel targets of cancer chemotherapy. A new camptothecin (CPT) analog, 7-ethyl-I0-[4-( I -piperidino)-I -piperidino]carbonyl-oxy-CPT (CPT-I I). is a topo-l inhibitor with a higher activity and less toxicity than CPT. To investigate topo-l a